Skip to content
Menu
origimm
Skin Microbiome
Indications
Acne Vulgaris
Background
Solution
For Patients
Acne Patients
Our motivation
Answers to frequent questions
About us
Company
Leadership Team
Our vision
News
Join us
Open positions
Stakeholders
Contact
Contact
Location
Origimm Clinical Trial_Homepage Press Release
Origimm Clinical Trial_Homepage Press Release
Post navigation
Previous Post
ORIGIMM Biotechnology Initiates First-in-Human Trial of Acne Vulgaris Vaccine